Search by Drug Name or NDC

    NDC 00009-7529-05 Camptosar 20 mg/mL Details

    Camptosar 20 mg/mL

    Camptosar is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pharmacia & Upjohn Company LLC. The primary component is IRINOTECAN HYDROCHLORIDE.

    Product Information

    NDC 00009-7529
    Product ID 0009-7529_ece2f47a-8151-4f84-80ec-16cc3a7dec6a
    Associated GPIs 21550040102030 21550040102025 21550040102035
    GCN Sequence Number 062174
    GCN Sequence Number Description irinotecan HCl VIAL 100 MG/5ML INTRAVEN
    HIC3 V3E
    HIC3 Description ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS
    GCN 97956
    HICL Sequence Number 010778
    HICL Sequence Number Description IRINOTECAN HCL
    Brand/Generic Brand
    Proprietary Name Camptosar
    Proprietary Name Suffix n/a
    Non-Proprietary Name irinotecan hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name IRINOTECAN HYDROCHLORIDE
    Labeler Name Pharmacia & Upjohn Company LLC
    Pharmaceutical Class Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020571
    Listing Certified Through 2024-12-31

    Package

    NDC 00009-7529-05 (00009752905)

    NDC Package Code 0009-7529-05
    Billing NDC 00009752905
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529-05) / 15 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 1996-06-14
    NDC Exclude Flag N
    Pricing Information N/A